|
1
|
Aarabi S, Longaker MT and Gurtner GC:
Hypertrophic scar formation following burns and trauma: New
approaches to treatment. PLoS Med. 4:e2342007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xiao Z, Zhang M, Liu Y and Ren L:
Botulinum toxin type a inhibits connective tissue growth factor
expression in fibroblasts derived from hypertrophic scar. Aesthetic
Plast Surg. 35:802–807. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun Z, Li S, Cao C, Wu J, Ma B and Tran V:
shRNA targeting SFRP2 promotes the apoptosis of hypertrophic scar
fibroblast. Mol Cell Biochem. 352:25–33. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu XJ, Xu MJ, Fan ST, Wu Z, Li J, Yang
XM, Wang YH, Xu J and Zhang ZG: Xiamenmycin attenuates hypertrophic
scars by suppressing local inflammation and the effects of
mechanical stress. J Invest Dermatol. 133:1351–1360. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang D, Shen KH and Wang HG: Pressure
therapy upregulates matrix metalloproteinase expression and
downregulates collagen expression in hypertrophic scar tissue. Chin
Med J (Engl). 126:3321–3324. 2013.
|
|
6
|
Gauglitz GG, Korting HC, Pavicic T,
Ruzicka T and Jeschke MG: Hypertrophic scarring and keloids:
Pathomechanisms and current and emerging treatment strategies. Mol
Med. 17:113–125. 2011. View Article : Google Scholar :
|
|
7
|
Liu BH, Chen L, Li SR, Wang ZX and Cheng
WG: Smac/DIABLO regulates the apoptosis of hypertrophic scar
fibroblasts. Int J Mol Med. 32:615–622. 2013.PubMed/NCBI
|
|
8
|
Simon F, Bergeron D, Larochelle S,
Lopez-Vallé CA, Genest H, Armour A and Moulin VJ: Enhanced
secretion of TIMP-1 by human hypertrophic scar keratinocytes could
contribute to fibrosis. Burns. 38:421–427. 2012. View Article : Google Scholar
|
|
9
|
Yin L, Zhao X, Ji S, He C, Wang G, Tang C,
Gu S and Yin C: The use of gene activated matrix to mediate
effective SMAD2 gene silencing against hypertrophic scar.
Biomaterials. 35:2488–2498. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu S, Jiang L, Li H, Shi H, Luo H, Zhang
Y, Yu C and Jin Y: Mesenchymal stem cells prevent hypertrophic scar
formation via inflammatory regulation when undergoing apoptosis. J
Invest Dermatol. 134:2648–2657. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang R, Ghahary A, Shen Q, Scott PG, Roy K
and Tredget EE: Hypertrophic scar tissues and fibroblasts produce
more transforming growth factor-beta1 mRNA and protein than normal
skin and cells. Wound Repair Regen. 8:128–137. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ehrlich HP, Desmoulière A, Diegelmann RF,
Cohen IK, Compton CC, Garner WL, Kapanci Y and Gabbiani G:
Morphological and immunochemical differences between keloid and
hypertrophic scar. Am J Pathol. 145:105–113. 1994.PubMed/NCBI
|
|
13
|
Varga J and Abraham D: Systemic sclerosis:
A prototypic multi-system fibrotic disorder. J Clin Invest.
117:557–567. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Colwell AS, Phan TT, Kong W, Longaker MT
and Lorenz PH: Hypertrophic scar fibroblasts have increased
connective tissue growth factor expression after transforming
growth factor-beta stimulation. Plast Reconstr Surg. 116:1387–1392.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen X, Yang L, Oppenheim JJ and Howard
MZ: Cellular pharmacology studies of shikonin derivatives.
Phytother Res. 16:199–209. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jones LJ, Gray M, Yue ST, Haugland RP and
Singer VL: Sensitive determination of cell number using the CyQUANT
cell proliferation assay. J Immunol Methods. 254:85–98. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Malkusch W, Rehn B and Bruch J: Advantages
of Sirius Red staining for quantitative morphometric collagen
measurements in lungs. Exp Lung Res. 21:67–77. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singer AJ and Clark RA: Cutaneous wound
healing. N Engl J Med. 341:738–746. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Urioste SS, Arndt KA and Dover JS: Keloids
and hypertrophic scars: Review and treatment strategies. Semin
Cutan Med Surg. 18:159–171. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Piek E, Moustakas A, Kurisaki A, Heldin CH
and ten Dijke P: TGF-(beta) type I receptor/ALK-5 and Smad proteins
mediate epithelial to mesenchymal transdifferentiation in NMuMG
breast epithelial cells. J Cell Sci. 112:4557–4568. 1999.PubMed/NCBI
|
|
21
|
Wrana JL and Attisano L: The Smad pathway.
Cytokine Growth Factor Rev. 11:5–13. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Massague J: Integration of Smad and MAPK
pathways: A link and a linker revisited. Genes Dev. 17:2993–2997.
2003. View Article : Google Scholar
|
|
23
|
Inman GJ: Linking Smads and
transcriptional activation. Biochem J. 386:e1–e3. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hough C, Radu M and Doré JJ: Tgf-beta
induced Erk phosphorylation of smad linker region regulates smad
signaling. PLoS One. 7:e425132012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Derynck R and Zhang YE: Smad-dependent and
Smad-independent pathways in TGF-beta family signalling. Nature.
425:577–584. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li J, Zhao Z, Liu J, Huang N, Long D, Wang
J, Li X and Liu Y: MEK/ERK and p38 MAPK regulate chondrogenesis of
rat bone marrow mesenchymal stem cells through delicate interaction
with TGF-beta1/Smads pathway. Cell Prolif. 43:333–343. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Darby IA and Hewitson TD: Fibroblast
differentiation in wound healing and fibrosis. Int Rev Cytol.
257:143–179. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang Z, Garron TM, Li XJ, Liu Y, Zhang X,
Li YY and Xu WS: Recombinant human decorin inhibits TGF-β1-induced
contraction of collagen lattice by hypertrophic scar fibroblasts.
Burns. 35:527–537. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Franz M, Spiegel K, Umbreit C, Richter P,
Codina-Canet C, Berndt A, Altendorf-Hofmann A, Koscielny S, Hyckel
P, Kosmehl H, et al: Expression of Snail is associated with
myofibroblast phenotype development in oral squamous cell
carcinoma. Histochem Cell Biol. 131:651–660. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ibrahim MM, Bond J, Bergeron A, Miller KJ,
Ehanire T, Quiles C, Lorden ER, Medina MA, Fisher M, Klitzman B, et
al: A novel immune competent murine hypertrophic scar contracture
model: A tool to elucidate disease mechanism and develop new
therapies. Wound Repair Regen. 22:755–764. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Dodd C, Shankowsky HA, Scott PG
and Tredget EE; Wound Healing Research Group: Deep dermal
fibroblasts contribute to hypertrophic scarring. Lab Invest.
88:1278–1290. 2008. View Article : Google Scholar : PubMed/NCBI
|
